Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Saltz

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials ProgramChristopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Molecular Cancer Research : MCR|December 15, 2015
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAFJaclyn F Hechtman, Ahmet Zehir, Rona Yaeger, et al.
Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.
Oncotarget|December 10, 2016
MicroRNA-203 predicts human survival after resection of colorectal liver metastasisT Peter Kingham, Hoang C B Nguyen, Jian Zheng, et al.
Cancer|October 15, 2013
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trialCharles S Fuchs, Marwan Fakih, Lee Schwartzberg, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
Annals of Surgery|June 6, 2012
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding, David Liska, Peter Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridolManish A Shah, Jeremy Kortmansky, Monica Motwani, et al.
JCO Precision Oncology|April 23, 2019
Majority of <i>B2M</i>-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.
Journal of the National Cancer Institute|September 25, 2014
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatmentAtthaphorn Trakarnsanga, Mithat Gönen, Jinru Shia, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials ProgramChristopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Molecular Cancer Research : MCR|December 15, 2015
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAFJaclyn F Hechtman, Ahmet Zehir, Rona Yaeger, et al.
Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.
Oncotarget|December 10, 2016
MicroRNA-203 predicts human survival after resection of colorectal liver metastasisT Peter Kingham, Hoang C B Nguyen, Jian Zheng, et al.
Cancer|October 15, 2013
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trialCharles S Fuchs, Marwan Fakih, Lee Schwartzberg, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
Annals of Surgery|June 6, 2012
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding, David Liska, Peter Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridolManish A Shah, Jeremy Kortmansky, Monica Motwani, et al.
JCO Precision Oncology|April 23, 2019
Majority of <i>B2M</i>-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.
Journal of the National Cancer Institute|September 25, 2014
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatmentAtthaphorn Trakarnsanga, Mithat Gönen, Jinru Shia, et al.
Pageof 17